276 related articles for article (PubMed ID: 12566376)
1. Myocardial infarct expansion and matrix metalloproteinase inhibition.
Mukherjee R; Brinsa TA; Dowdy KB; Scott AA; Baskin JM; Deschamps AM; Lowry AS; Escobar GP; Lucas DG; Yarbrough WM; Zile MR; Spinale FG
Circulation; 2003 Feb; 107(4):618-25. PubMed ID: 12566376
[TBL] [Abstract][Full Text] [Related]
2. Matrix metalloproteinase inhibition modifies left ventricular remodeling after myocardial infarction in pigs.
Yarbrough WM; Mukherjee R; Brinsa TA; Dowdy KB; Scott AA; Escobar GP; Joffs C; Lucas DG; Crawford FA; Spinale FG
J Thorac Cardiovasc Surg; 2003 Mar; 125(3):602-10. PubMed ID: 12658202
[TBL] [Abstract][Full Text] [Related]
3. Accelerated LV remodeling after myocardial infarction in TIMP-1-deficient mice: effects of exogenous MMP inhibition.
Ikonomidis JS; Hendrick JW; Parkhurst AM; Herron AR; Escobar PG; Dowdy KB; Stroud RE; Hapke E; Zile MR; Spinale FG
Am J Physiol Heart Circ Physiol; 2005 Jan; 288(1):H149-58. PubMed ID: 15598866
[TBL] [Abstract][Full Text] [Related]
4. Selective matrix metalloproteinase inhibition reduces left ventricular remodeling but does not inhibit angiogenesis after myocardial infarction.
Lindsey ML; Gannon J; Aikawa M; Schoen FJ; Rabkin E; Lopresti-Morrow L; Crawford J; Black S; Libby P; Mitchell PG; Lee RT
Circulation; 2002 Feb; 105(6):753-8. PubMed ID: 11839633
[TBL] [Abstract][Full Text] [Related]
5. Evolution of matrix metalloprotease and tissue inhibitor expression during heart failure progression in the infarcted rat.
Peterson JT; Li H; Dillon L; Bryant JW
Cardiovasc Res; 2000 May; 46(2):307-15. PubMed ID: 10773235
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of matrix metalloproteinases improves left ventricular function in mice lacking osteopontin after myocardial infarction.
Krishnamurthy P; Peterson JT; Subramanian V; Singh M; Singh K
Mol Cell Biochem; 2009 Feb; 322(1-2):53-62. PubMed ID: 18979185
[TBL] [Abstract][Full Text] [Related]
7. Matrix metalloproteinase inhibition attenuates left ventricular remodeling and dysfunction in a rat model of progressive heart failure.
Peterson JT; Hallak H; Johnson L; Li H; O'Brien PM; Sliskovic DR; Bocan TM; Coker ML; Etoh T; Spinale FG
Circulation; 2001 May; 103(18):2303-9. PubMed ID: 11342481
[TBL] [Abstract][Full Text] [Related]
8. Selective targeting and timing of matrix metalloproteinase inhibition in post-myocardial infarction remodeling.
Yarbrough WM; Mukherjee R; Escobar GP; Mingoia JT; Sample JA; Hendrick JW; Dowdy KB; McLean JE; Lowry AS; O'Neill TP; Spinale FG
Circulation; 2003 Oct; 108(14):1753-9. PubMed ID: 12975256
[TBL] [Abstract][Full Text] [Related]
9. Chronic matrix metalloproteinase inhibition following myocardial infarction in mice: differential effects on short and long-term survival.
Spinale FG; Escobar GP; Hendrick JW; Clark LL; Camens SS; Mingoia JP; Squires CG; Stroud RE; Ikonomidis JS
J Pharmacol Exp Ther; 2006 Sep; 318(3):966-73. PubMed ID: 16757539
[TBL] [Abstract][Full Text] [Related]
10. Selective targeting of matrix metalloproteinase inhibition in post-infarction myocardial remodeling.
Apple KA; Yarbrough WM; Mukherjee R; Deschamps AM; Escobar PG; Mingoia JT; Sample JA; Hendrick JW; Dowdy KB; McLean JE; Stroud RE; O'Neill TP; Spinale FG
J Cardiovasc Pharmacol; 2006 Feb; 47(2):228-35. PubMed ID: 16495760
[TBL] [Abstract][Full Text] [Related]
11. Myocardial and interstitial matrix metalloproteinase activity after acute myocardial infarction in pigs.
Etoh T; Joffs C; Deschamps AM; Davis J; Dowdy K; Hendrick J; Baicu S; Mukherjee R; Manhaini M; Spinale FG
Am J Physiol Heart Circ Physiol; 2001 Sep; 281(3):H987-94. PubMed ID: 11514263
[TBL] [Abstract][Full Text] [Related]
12. Delivery of a matrix metalloproteinase-responsive hydrogel releasing TIMP-3 after myocardial infarction: effects on left ventricular remodeling.
Purcell BP; Barlow SC; Perreault PE; Freeburg L; Doviak H; Jacobs J; Hoenes A; Zellars KN; Khakoo AY; Lee T; Burdick JA; Spinale FG
Am J Physiol Heart Circ Physiol; 2018 Oct; 315(4):H814-H825. PubMed ID: 29979624
[TBL] [Abstract][Full Text] [Related]
13. Selective matrix metalloproteinase inhibition with developing heart failure: effects on left ventricular function and structure.
King MK; Coker ML; Goldberg A; McElmurray JH; Gunasinghe HR; Mukherjee R; Zile MR; O'Neill TP; Spinale FG
Circ Res; 2003 Feb; 92(2):177-85. PubMed ID: 12574145
[TBL] [Abstract][Full Text] [Related]
14. MMP/TIMP expression in spontaneously hypertensive heart failure rats: the effect of ACE- and MMP-inhibition.
Li H; Simon H; Bocan TM; Peterson JT
Cardiovasc Res; 2000 May; 46(2):298-306. PubMed ID: 10773234
[TBL] [Abstract][Full Text] [Related]
15. Myocardial overexpression of TIMP3 after myocardial infarction exerts beneficial effects by promoting angiogenesis and suppressing early proteolysis.
Takawale A; Zhang P; Azad A; Wang W; Wang X; Murray AG; Kassiri Z
Am J Physiol Heart Circ Physiol; 2017 Aug; 313(2):H224-H236. PubMed ID: 28550172
[TBL] [Abstract][Full Text] [Related]
16. Effect of matrix metalloproteinase inhibition by doxycycline on myocardial healing and remodeling after myocardial infarction.
Tessone A; Feinberg MS; Barbash IM; Reich R; Holbova R; Richmann M; Mardor Y; Leor J
Cardiovasc Drugs Ther; 2005 Dec; 19(6):383-90. PubMed ID: 16435072
[TBL] [Abstract][Full Text] [Related]
17. ET(A)-receptor blockade prevents matrix metalloproteinase activation late postmyocardial infarction in the rat.
Podesser BK; Siwik DA; Eberli FR; Sam F; Ngoy S; Lambert J; Ngo K; Apstein CS; Colucci WS
Am J Physiol Heart Circ Physiol; 2001 Mar; 280(3):H984-91. PubMed ID: 11179039
[TBL] [Abstract][Full Text] [Related]
18. Discordant activation of gene promoters for matrix metalloproteinases and tissue inhibitors of the metalloproteinases following myocardial infarction.
Mukherjee R; Snipes JM; Saunders SM; Zavadzkas JA; Spinale FG
J Surg Res; 2012 Jan; 172(1):59-67. PubMed ID: 20863528
[TBL] [Abstract][Full Text] [Related]
19. Angiotensin-converting enzyme and matrix metalloproteinase inhibition with developing heart failure: comparative effects on left ventricular function and geometry.
McElmurray JH; Mukherjee R; New RB; Sampson AC; King MK; Hendrick JW; Goldberg A; Peterson TJ; Hallak H; Zile MR; Spinale FG
J Pharmacol Exp Ther; 1999 Nov; 291(2):799-811. PubMed ID: 10525103
[TBL] [Abstract][Full Text] [Related]
20. TIMP2 deficiency accelerates adverse post-myocardial infarction remodeling because of enhanced MT1-MMP activity despite lack of MMP2 activation.
Kandalam V; Basu R; Abraham T; Wang X; Soloway PD; Jaworski DM; Oudit GY; Kassiri Z
Circ Res; 2010 Mar; 106(4):796-808. PubMed ID: 20056917
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
